QbDVision Co-Founder and CEO Yash Sabharwal participated in a PharmTech panel discussing how digitizing product and process knowledge can cut tech transfer timelines from 8 months to 8 weeks.
Published
Signal category
Presence & Recognition
Quote
“QbDVision Co-Founder and CEO Yash Sabharwal recently sat down for a PharmTech (Pharmaceutical Technology) panel on tech transfer”
— QbDVision team
Company
QbDVision
QbDVision is the leading Digital CMC Platform for pharmaceutical and biotech manufacturing.
- Industry
- Software Development
- Location
- Austin, US
- Company size
- 68 employees
QbDVision is the leading Digital CMC Platform for pharmaceutical and biotech manufacturing. Created by industry veterans with decades of drug development experience, we understand the challenges our platform was built to solve. We are preparing our industry to deliver on its promise. We’re creating the modern digital tools our industry needs to realize the full potential of its science. A platform to help organizations swiftly and efficiently deliver the next generation of breakthrough therapies.